MarkAndrewSchroederMD

PubMed

• 2 citations
  Acute Graft-versus-Host Disease: An Update on New Treatment Options.
  Dilan A Patel, Mallory Crain, Iskra Pusic, Mark A Schroeder> ;Drugs. 2023 Jul 1
• 12 citations
  Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
  Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe, Keith Stockerl-Goldstein, Sarah M Larson, Illes Arpad, Giulio A Milone, Massimo Martino, Patrick Stiff, Douglas ...> ;Nature Medicine. 2023 Apr 1
• 1 citations
  A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodyspl...
  Armin Rashidi, Eric J Huselton, Heather E Stefanski, Todd E DeFor, Ryan Shanley, Jaebok Choi, John F DiPersio, Mark Juckett, Jeffrey S Miller, Daniel J Weisdorf, Mark ...> ;Transplantation and Cellular Therapy. 2023 May 1
• 2 citations
  A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease.
  Michael Pratta, Sophie Paczesny, Gerard Socie, Natalie Barkey, Hao Liu, Sherry Owens, Michael C Arbushites, Mark A Schroeder, Michael D Howell> ;British Journal of Haematology. 2022 Aug 1
• 1 citations
  Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program.
  Mark A Schroeder, Parameswaran N Hari, Amy Blithe, Dilan Paranagama, Valkal Bhatt, John F DiPersio> ;Bone Marrow Transplantation. 2022 Jun 1
• 17 citations
  Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality.
  Lawrence Wayne Liu, Alicia Yn, Feng Gao, Marissa Olson, Mallory Crain, Ramzi Abboud, Peter Westervelt, Camille Abboud, Ravi Vij, Keith Stockerl-Goldstein, Iskra Pusic,...> ;Transplantation and Cellular Therapy. 2022 Aug 1
• 3 citations
  Decitabine salvage for-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
  Francesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, Christopher A Miller, Mary Elizabeth Percival, Geoffrey L Uy, Iskra Pusic, Meagan A Jacoby, Mathew J Christ...> ;Haematologica. 2022 Jul 1
• 41 citations
  Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia.
  Melissa M Berrien-Elliott, Jennifer A Foltz, David A Russler-Germain, Carly C Neal, Jennifer Tran, Margery Gang, Pamela Wong, Bryan Fisk, Celia C Cubitt, Nancy D Marin...> ;Science Translational Medicine. 2022 Feb 23
• 2 citations
  Mouse models of graft-versus-host disease.
  Dilan A Patel, Mark A Schroeder, Jaebok Choi, John F DiPersio> ;Methods in Cell Biology. 2022 Jan 1
• 20 citations
  Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomi...
  Robert Zeiser, Gérard Socié, Mark A Schroeder, Sunil Abhyankar, Carlos Pinho Vaz, Mi Kwon, Johannes Clausen, Leonid Volodin, Sebastian Giebel, Manuel Jurado Chacon, Ga...> ;The Lancet. Haematology. 2022 Jan 1
• 34 citations
  Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
  Melissa M. Berrien-Elliott, Michelle Becker-Hapak, Amanda F. Cashen, Miriam T. Jacobs, Pamela Wong, Mark P. Foster, Ethan McClain, Sweta Desai, Patrick Pence, Sarah Co...> ;Blood. 2021 Nov 19
• 2 citations
  Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
  Oren Pasvolsky, Moshe Yeshurun, Raphael Fraser, Noel Estrada-Merly, Uri Rozovski, Liat Shargian-Alon, Amer Assal, Rahul Banerjee, Naresh Bumma, Robert Peter Gale, Patr...> ;Bone Marrow Transplantation. 2021 Oct 4
• 10 citations
  Daratumumab for the treatment of multiple myeloma.
  Scott R. Goldsmith, N Foley, Mark A. Schroeder> ;Drugs of Today. 2021 Oct 1
• 8 citations
  Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
  Jingyu Xiang, Min Shi, Mark A. Fiala, Feng Gao, Michael P. Rettig, Geoffrey L. Uy, Mark A. Schroeder, Katherine N. Weilbaecher, Keith Stockerl-Goldstein, S. Mollah, Jo...> ;Blood Advances. 2021 Sep 23
• 7 citations
  Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS.
  Eric Huselton, Michael P. Rettig, Kirsten Campbell, Amanda F. Cashen, John F. DiPersio, Feng Gao, Meagan A. Jacoby, Iskra Pusic, Rizwan Romee, Mark A. Schroeder, Geoff...> ;Leukemia Research. 2021 Nov 1
• 3 citations
  Methods for intratumoral microdialysis probe targeting and validation in murine brain tumor models
  Karishma Rajani, Ian Olson, Joshua J. Jacobs, Cecile Riviere-Cazaux, Kirsten Burns, Lucas P. Carlstrom, Mark A. Schroeder, Juhee Oh, Charles L. Howe, Masum Rahman, Jan...> ;Journal of Neuroscience Methods. 2021 Nov 1
• HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
  Mahasweta Gooptu, Rizwan Romee, Andrew St Martin, Mukta Arora, Monzr Al Malki, Joseph H Antin, Christopher N Bredeson, Claudio G Brunstein, Saurabh Chhabra, Ephraim J ...> ;Blood. 2021 Jul 22
• 4 citations
  Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis.
  Sameem Abedin, Nahid Rashid, Mark A. Schroeder, Rizwan Romee, Mary Nauffal, Muhamad Alhaj Moustafa, Mohamed A. Kharfan-Dabaja, Jeanne Palmer, William J. Hogan, Mehrdad...> ;British Journal of Haematology. 2021 Jul 12
• 4 citations
  Preclinical modeling in GBM PDX xenografts to guide clinical development of lisavanbulin - a novel tumor checkpoint controller targeting microtubules.
  Danielle M. Burgenske, Surabhi Talele, Jenny L. Pokorny, Ann C. Mladek, Katrina K. Bakken, Brett L. Carlson, Mark A. Schroeder, Lihong He, Zeng Hu, Gautham Gampa, Matt...> ;Neuro-Oncology. 2021 Jul 7
• 1 citations
  A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma.
  Lawrence Liu, Mark Fiala, Feng Gao, Justin King, Scott R. Goldsmith, Tanya M. Wildes, Keith Stockerl-Goldstein, Ravi Vij, Mark A. Schroeder> ;Leukemia & Lymphoma. 2021 Jun 18
• 8 citations
  A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
  Yngvar Fløisand, Mark A. Schroeder, Patrice Chevallier, Dominik Selleslag, Steven M. Devine, Anne S. Renteria, Mohamad Mohty, Ibrahim Yakoub-Agha, Chunlin Chen, Andrej...> ;Bone Marrow Transplantation. 2021 Jun 9
• 2 citations
  Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78.
  Mark A. Fiala, Justin King, Daniel Feinberg, Scott R. Goldsmith, Mark A. Schroeder, Armin Ghobadi, Keith Stockerl-Goldstein, Ravi Vij, Tanya M. Wildes> ;Bone Marrow Transplantation. 2021 Apr 19
• 8 citations
  In Vivo Efficacy of Tesevatinib in EGFR-Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling.
  Sani H. Kizilbash, Shiv K. Gupta, Karen E. Parrish, Janice K. Laramy, Minjee Kim, Gautham Gampa, Brett L. Carlson, Katrina K. Bakken, Ann C. Mladek, Mark A. Schroeder,...> ;Molecular Cancer Therapeutics. 2021 Mar 30
• 25 citations
  Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance.
  Mohammad Jalalirad, Tufia C. Haddad, Jeffrey L. Salisbury, Derek C. Radisky, Minzhi Zhang, Mark A. Schroeder, Ann C. Mladek Tuma, Eduard Leof, Jodi M. Carter, Amy C. D...> ;Oncogene. 2021 Mar 5
• 3 citations
  A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes
  Eric Huselton, Michael P. Rettig, Theresa Fletcher, Julie Ritchey, Leah Gehrs, Kyle McFarland, Stephanie Christ, William C. Eades, Kathryn Trinkaus, Rizwan Romee, Shas...> ;Leukemia & Lymphoma. 2021 Jan 19
• Join now to see all

Journal Articles

• Single Institution Experience with G-CSF Mobilized T-cell Replete Haploidentical Hematopoietic Cell Transplantation  
  M A Schroeder, R Romee, J F DiPersio, T A Fehniger, F Gao, G L Uy, C N Abboud, P Westervelt, R Vij, Nature

Abstracts/Posters

• Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDSClinically Relevant Abst...
  Mark A. Schroeder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Ire of IRE1_: Overexpression of IRE1_ at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1_ Expression Is Predictive of Therapy ...
  Mark A. Schroeder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Dysregulated Mirnas after Uniform Treatment Predict Outcome of Newly-Diagnosed Multiple Myeloma
  Mark A. Schroeder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019